nav mail map-pin

We have a successful track record in sourcing, structuring and exiting seed and spin-out companies.

The team of
Life Sciences Fund Amsterdam

The management team of the Life Sciences Fund Amsterdam has a successful track record in sourcing, structuring and exiting seed and spin-out companies. Such experience and track-record allows the fund to provide the required hands-on operational assistance to the fund’s portfolio companies.

Tom Schwarz
Tom Schwarz
Partner

Tom Schwarz started his venture capital career in 1998, when he co-founded Life Sciences Partners (LSP), a leading European life . ...

Visit Tom's profile
Harm de Vries
Harm de Vries
Partner

Harm de Vries has been active in the private equity industry for 15 years. Harm has structured portfolio investments (>50), exits ...

Visit Harm's profile

Our
companies

We concentrate on bringing to market disruptive innovations in life sciences, physical sciences (physics and chemistry), and information technology, and specialize in the spaces where they converge.

Visit our complete portfolio
  • ACS Biomarker BV
  • AIMM Therapeutics
  • Caelus Pharmaceuticals
  • Mirnext
  • Regenesance
  • Sigma Screening